Why did Dr. Phil’s TV network file bankruptcy?
How will OPEC+ oil hike impact prices?
What caused Datadog’s stock surge after S&P inclusion?
Why is Lululemon’s lawsuit boosting Costco’s marketing?
How will Trump’s ‘Big Beautiful Bill’ affect taxes?
Why is the US imposing new tariffs on 12 countries?
What explains the surge in US stock trading volume?
Regeneron's Lynozyfic Gains Accelerated FDA Approval For Heavily Pre-Treated Multiple Myeloma
benzinga.com/news/fda/25/07/46244666/regenerons-lynozyfic-gains-accelerated-fda-approval-for-heavily-pre-treated-multiple-myeloma
The U.S. Food and Drug Administration (FDA) granted accelerated approval to Regeneron Pharmaceuticals, Inc.’s (NASDAQ:REGN) Lynozyfic (linvoseltamab-gcpt) for adult patients with relapsed or refractory (R/R) multiple myeloma (MM) who have received at least four prior lines of…
This story appeared on benzinga.com, 2025-07-03 13:37:41.